FDA Clearance Tracker · K162833
VitriGuard
Last checked: Nov 20, 2026Latest source record: Feb 16, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Feb 16, 2017
Substantially Equivalent
Time to decision
128 days
Received Oct 11, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K162833
- Device name
- VitriGuard
- Applicant
- Origio A/S
- Applicant location
- MåLøV, DK
- Received
- Oct 11, 2016
- Decided
- Feb 16, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Labware, Assisted Reproduction (MQK)
- Device class
- Class II
- Regulation
- 21 CFR 884.6160
- Specialty
- Obstetrics & Gynecology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MQK. The earliest in FDA's data is K991249, decided May 5, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K162833
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Origio A/S
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Synvitro Hyadase510(k)
K200680 · Decided Jul 17, 2020 · 123 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
- VitriGuard510(k)
K200815 · Decided Jun 25, 2020 · 87 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
- VitriGuard510(k)
K180740 · Decided May 4, 2018 · 43 days after receipt
Device type: Labware, Assisted Reproduction (MQK) · Obstetrics & Gynecology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.